The use of Cortiva® Allograft Dermis in two-staged breast reconstruction: A matched-comparison and cost analyses study
Journal of Plastic, Reconstructive & Aesthetic Surgery · 2025
DOI: 10.1016/j.bjps.2024.11.024 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2025. Verfasst von Eugene E Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Acellular Dermis, Mammaplasty. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Acellular dermal matrices (ADM) are an adjunct in implant-based breast reconstruction. While clinical outcomes have generally been equivocal between brands, a cost analysis between these brands has yet to be conducted. This study reports a single, academic institution's experience with 2 ADM brands in breast reconstruction and provides data on clinical and financial outcomes. METHODS: A retrospective chart review of patients who underwent two-staged breast reconstruction with Cortiva® Allograft Dermis ® was matched with a cohort who received AlloDerm RTU. Comparison of clinical outcomes, such as complications and revision surgeries, in addition to a cost analysis was completed. RESULTS: The study cohort included 24 patients who received Cortiva® and 24 patients who received AlloDerm. There were no statistical differences in demographics or breast-specific characteristics between the cohorts. Major complications were not statistically increased with Cortiva® use [Hazard Ratio 1.78 (0.421-7.66)], but the rate of revision following second-stage reconstruction trended toward significance with Cortiva® use [3.41 (0.99-11.80), p=0.05]. The material base cost and total cost following surgeries were lower for Cortiva® (44% of the AlloDerm costs) but the incremental costs did not display significant difference secondary to comparable complication and revision rates. CONCLUSIONS: The use of Cortiva® Allograft Dermis was shown to have a decreased cost in base material and total cost associated with surgery while also displaying comparable clinical outcomes and complication rate. Additional studies examining patient-reported outcomes would complement the growing literature comparing ADM brands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Plastic Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA.
- University of Minnesota Medical School, Minneapolis, MN, USA.
- Division of Plastic Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA; Universidad Especialidades Espiritu Santo, Samborondon, Ecuador.
- Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
- Division of Plastic Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA. Electronic address: MartinezJorge.Jorys@mayo.edu.
Zitieren
APA
Zheng, E. E., Kuruoglu, D., Cespedes-Gomez, O., Sanchez Figueroa, N., Vierkant, R. A., Vijayasekaran, A., & Martinez-Jorge, J. (2025). The use of Cortiva® Allograft Dermis in two-staged breast reconstruction: A matched-comparison and cost analyses study. Journal of Plastic, Reconstructive & Aesthetic Surgery. https://doi.org/10.1016/j.bjps.2024.11.024
Vancouver
Zheng EE, Kuruoglu D, Cespedes-Gomez O, Sanchez Figueroa N, Vierkant RA, Vijayasekaran A, et al. The use of Cortiva® Allograft Dermis in two-staged breast reconstruction: A matched-comparison and cost analyses study. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2025. doi:10.1016/j.bjps.2024.11.024
BibTeX
@article{Zheng2025,
author = {Zheng, Eugene E and Kuruoglu, Doga and Cespedes-Gomez, Omar and Sanchez Figueroa, Nicole and Vierkant, Robert A and Vijayasekaran, Aparna and Martinez-Jorge, Jorys},
title = {The use of Cortiva® Allograft Dermis in two-staged breast reconstruction: A matched-comparison and cost analyses study},
journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
year = {2025},
doi = {10.1016/j.bjps.2024.11.024}
}
EUVIMED